| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |